Published in Trop Med Int Health on June 01, 2004
Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg (2007) 4.51
Care-seeking patterns for fatal malaria in Tanzania. Malar J (2004) 3.41
Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One (2009) 3.11
Access to health care in contexts of livelihood insecurity: a framework for analysis and action. PLoS Med (2007) 2.89
Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health Policy Plan (2007) 2.35
Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J (2007) 2.33
Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Malar J (2007) 2.25
Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malar J (2006) 2.09
The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J (2011) 2.03
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malar J (2006) 1.72
A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv Res (2010) 1.58
Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector. Malar J (2005) 1.39
Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J (2013) 1.37
Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malar J (2010) 1.35
Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania. BMC Public Health (2008) 1.31
Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Health Econ (2009) 1.25
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine. Malar J (2010) 1.19
The quest for universal access to effective malaria treatment: how can the AMFm contribute? Malar J (2010) 1.17
Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries. Malar J (2013) 1.14
Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT). Malar J (2011) 1.12
Are patent medicine vendors effective agents in malaria control? Using lot quality assurance sampling to assess quality of practice in Jigawa, Nigeria. PLoS One (2012) 1.00
Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies. PLoS One (2014) 0.99
Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy. Malar J (2014) 0.96
"We have become doctors for ourselves": motives for malaria self-care among adults in southeastern Tanzania. Malar J (2014) 0.95
Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys. Malar J (2013) 0.91
Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya. BMC Public Health (2010) 0.89
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination. Malar J (2011) 0.86
Potential barriers to healthcare in Malawi for under-five children with cough and fever: a national household survey. J Health Popul Nutr (2014) 0.82
Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regions. Malar J (2016) 0.80
Patterns of treatment-seeking behaviors among caregivers of febrile young children: a Ugandan multiple case study. BMC Public Health (2016) 0.80
Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania. BMC Res Notes (2012) 0.78
Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania. Afr Health Sci (2011) 0.78
Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective. Malar Res Treat (2011) 0.77
Discovering the cost of care: consumer, provider, and retailer surveys shed light on the determinants of malaria health-seeking behaviours. Malar J (2016) 0.75
The fallacy of competing interest statements: no shortcut to rigour in research. J R Soc Med (2009) 0.75
Introducing rapid tests for malaria into the retail sector: what are the unintended consequences? BMJ Glob Health (2017) 0.75
Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43
Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med (2007) 13.43
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg (2004) 8.13
Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med (2007) 6.80
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Maternal health in poor countries: the broader context and a call for action. Lancet (2006) 4.72
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg (2007) 4.51
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
Health financing to promote access in low income settings-how much do we know? Lancet (2004) 4.31
An entomopathogenic fungus for control of adult African malaria mosquitoes. Science (2005) 4.27
Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania. Malar J (2011) 4.27
The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission. Lancet (2010) 4.24
Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ (2006) 4.12
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ (2008) 4.02
Factors affecting home delivery in rural Tanzania. Trop Med Int Health (2007) 3.91
Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya. Am J Trop Med Hyg (2003) 3.81
Improving the health of the global poor. Science (2002) 3.69
Mobilising financial resources for maternal health. Lancet (2006) 3.53
Challenges in routine implementation and quality control of rapid diagnostic tests for malaria--Rufiji District, Tanzania. Am J Trop Med Hyg (2008) 3.50
The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg (2007) 3.44
Care-seeking patterns for fatal malaria in Tanzania. Malar J (2004) 3.41
History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Assessing capacity for health policy and systems research in low and middle income countries* Health Res Policy Syst (2003) 3.29
Health-financing reforms in southeast Asia: challenges in achieving universal coverage. Lancet (2011) 3.14
Financing of health systems to achieve the health Millennium Development Goals in low-income countries. Lancet (2010) 3.10
Countdown to 2015: assessment of donor assistance to maternal, newborn, and child health between 2003 and 2006. Lancet (2008) 2.83
Is private health care the answer to the health problems of the world's poor? PLoS Med (2008) 2.82
Caution is required when using health facility-based data to evaluate the health impact of malaria control efforts in Africa. Malar J (2009) 2.75
Quantifying behavioural interactions between humans and mosquitoes: evaluating the protective efficacy of insecticidal nets against malaria transmission in rural Tanzania. BMC Infect Dis (2006) 2.60
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Dispensary level pilot implementation of rapid diagnostic tests: an evaluation of RDT acceptance and usage by providers and patients--Tanzania, 2005. Malar J (2008) 2.52
Mosquito nets and the poor: can social marketing redress inequities in access? Trop Med Int Health (2004) 2.44
The economic impact of malaria in Africa: a critical review of the evidence. Health Policy (2003) 2.42
Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health Policy Plan (2007) 2.35
Re-treatment of mosquito nets with insecticide. Trans R Soc Trop Med Hyg (2002) 2.35
Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003-08. Lancet (2010) 2.33
The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther (2013) 2.32
What can global health institutions do to help strengthen health systems in low income countries? Health Res Policy Syst (2010) 2.31
Consistently high estimates for the proportion of human exposure to malaria vector populations occurring indoors in rural Africa. Int J Epidemiol (2013) 2.30
Scaling-up and sustaining insecticide-treated net coverage. Lancet Infect Dis (2003) 2.27
Comparison of government statistics and demographic surveillance to monitor mortality in children less than five years old in rural western Kenya. Am J Trop Med Hyg (2003) 2.27
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis (2006) 2.26
Cost-effectiveness of social marketing of insecticide-treated nets for malaria control in the United Republic of Tanzania. Bull World Health Organ (2003) 2.26
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Do malaria control interventions reach the poor? A view through the equity lens. Am J Trop Med Hyg (2004) 2.23
Dual job holding by public sector health professionals in highly resource-constrained settings: problem or solution? Bull World Health Organ (2005) 2.22
Insecticide-treated bednet use, anaemia, and malaria parasitaemia in Blantyre District, Malawi. Trop Med Int Health (2002) 2.18
The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya I. Development of infrastructure and description of study site. Am J Trop Med Hyg (2003) 2.13
Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malar J (2006) 2.09
Countdown to 2015: tracking donor assistance to maternal, newborn, and child health. Lancet (2006) 2.08
Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial. PLoS Med (2009) 2.05
Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg (2010) 2.03
Real-time fluorescence loop mediated isothermal amplification for the diagnosis of malaria. PLoS One (2010) 2.02
Socially marketed insecticide-treated nets improve malaria and anaemia in pregnancy in southern Tanzania. Trop Med Int Health (2002) 2.00
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis (2013) 2.00
From Mexico to Mali: progress in health policy and systems research. Lancet (2008) 1.99
Reproductive health priorities: evidence from a resource tracking analysis of official development assistance in 2009 and 2010. Lancet (2013) 1.95
Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv Res (2009) 1.95
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health (2006) 1.91
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J (2008) 1.90
A nationwide survey of the quality of antimalarials in retail outlets in Tanzania. PLoS One (2008) 1.88
Scaling up priority health interventions in Tanzania: the human resources challenge. Health Policy Plan (2007) 1.86
Countdown to 2015: changes in official development assistance to maternal, newborn, and child health in 2009-10, and assessment of progress since 2003. Lancet (2012) 1.86
Quality assurance of rapid diagnostic tests for malaria in routine patient care in rural Tanzania. Am J Trop Med Hyg (2010) 1.83
Community reactions to the introduction of permethrin-treated bed nets for malaria control during a randomized controlled trial in western Kenya. Am J Trop Med Hyg (2003) 1.82
Distribution of free untreated bednets bundled with insecticide via an integrated child health campaign in Lindi Region, Tanzania: lessons for future campaigns. Am J Trop Med Hyg (2007) 1.81
Rift Valley fever outbreak in livestock in Kenya, 2006-2007. Am J Trop Med Hyg (2010) 1.78
Knowledge of malaria and its association with malaria-related behaviors--results from the Malaria Indicator Survey, Ethiopia, 2007. PLoS One (2010) 1.73
Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Am J Trop Med Hyg (2004) 1.72
Intervention complexity--a conceptual framework to inform priority-setting in health. Bull World Health Organ (2005) 1.72
Health policy and systems research: defining the terrain; identifying the methods. Health Policy Plan (2011) 1.72
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malar J (2006) 1.72
Use of antenatal care services and intermittent preventive treatment for malaria among pregnant women in Blantyre District, Malawi. Trop Med Int Health (2004) 1.71
Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy Childbirth (2014) 1.70
Markets, voucher subsidies and free nets combine to achieve high bed net coverage in rural Tanzania. Malar J (2008) 1.68
Is there evidence for dual causation between malaria and socioeconomic status? Findings from rural Tanzania. Am J Trop Med Hyg (2007) 1.65
Learning from Thailand's health reforms. BMJ (2004) 1.61
Health workers' use of malaria rapid diagnostic tests (RDTs) to guide clinical decision making in rural dispensaries, Tanzania. Am J Trop Med Hyg (2010) 1.59
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar J (2007) 1.58
Promoting universal financial protection: how the Thai universal coverage scheme was designed to ensure equity. Health Res Policy Syst (2013) 1.58
Why first-level health workers fail to follow guidelines for managing severe disease in children in the Coast Region, the United Republic of Tanzania. Bull World Health Organ (2009) 1.57
Risk factors for child mortality in rural Tanzania. Trop Med Int Health (2002) 1.55
Cost of increasing access to artemisinin combination therapy: the Cambodian experience. Malar J (2008) 1.55
Mass drug administration for malaria. Cochrane Database Syst Rev (2013) 1.54
The household costs of health care in rural South Africa with free public primary care and hospital exemptions for the poor. Trop Med Int Health (2009) 1.49
The Affordable Medicines Facility--malaria: killing it slowly. Lancet (2012) 1.47